Tummala, Rajit
Pearson, Erik
Antes, Avery
Slagowski, Jordan M.
Redler, Gage
Nilsson, Rasmus
Halpern, Howard J.
Sarigul, Neslihan
Ahmed, Ibrahim
Velarde, Daniela Olivera
Epel, Boris
Gertsenshteyn, Inna
Aydogan, Bulent
Article History
Received: 17 September 2024
Accepted: 6 May 2025
First Online: 22 May 2025
Declarations
:
: HJH and BE respectively hold US patent 8,664,955 (US-8664955-B1) and patent 9,392,957 (US-9392957-B1) for aspects of the pO2 imaging technology. Both individuals are also members of a start-up company O2M Technologies, LLC. The other authors declare no known commercial or financial relationships that could be construed as a potential conflict of interest for this research. All authors state that they have no other competing interests to disclose, including non-financial interests.
: The data used here was from a previous animal study approved by the University of Chicago Institutional Animal Care and Use Committee. This previous study was conducted in accordance with the local legislation, institutional requirements, and ARRIVE guidelines. All methods from this previous study followed US Public Health Service policy and NIH Guide for the Care and Use of Laboratory Animals.